Clinical and Biological Effects of Erythropoietin treatment of Myelodysplastic Syndrome

References

• Metcalf D. The molecular control of cell division, differentiation, commitment and maturation in haemopoietic cells. Nature 1989; 339: 27–30
   PubMed Web of Science ®Google Scholar
• Gabrilove J. L., Jakubowsky A., Scher D. H., Sternberg C., Wong G., Grous D. J., Yagoda A., Fain K., Moore M. A. S., Clarkson D. B., Oettgen H. F., Alton K., Welte D. K., Souza L. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. New England Journal of Medicine 1988; 318: 1414–22
   PubMed Web of Science ®Google Scholar
• Morstyn G., Campbell L., Souza L. M., Alton N. K., Keech J., Green M., Sherdian W., Metcalf D., Fox R. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667–72
   PubMed Web of Science ®Google Scholar
• Crawford J., Ozer H., Stoller L., Johnson D., Lyman G., Tabbara I., Kris M., Grous J., Picozzi V., Rausch G., Smith R., Gradishar W., Yahanda A., Vincent M., Stewart M., Glaspy J. Reduction by granulocyte colony-stimulating factors of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. New England Journal of Medicine 1991; 325: 164–70
   PubMed Web of Science ®Google Scholar
• Nemunaitis J., Rabinowe S. N., Singer J. W., Bierman P. J., Vose J. M., Freedman A. S., Onetto N., Gillis S., Oette D., Gold M., Buckner C. D., Hanson J. A., Ritz J., Appelbaum F. R., Armitage J. O., Nadler L. M. Recombinant granulocyte-macrophage colony-stimulating factor after auto-logous bone marrow transplantation for lymphoid cancer. New England Journal of Medicine 1991; 324: 1773–78
   PubMed Web of Science ®Google Scholar
• Eschback J. W., Kelly M. R., Haley N. R., Abels R. I., Adamson J. W. Treatment of the anemia of progressive renal failure with recombinant human ery-thropoietin. New England Journal of Medine 1989; 321: 158–163
   PubMed Web of Science ®Google Scholar
• Ludwig H., Fritz E., Kotzmann H., Hocker P., Gisslinger H., Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. New England Journal of Medicine 1990; 322: 1693–99
   PubMed Web of Science ®Google Scholar
• Fischl M., Galpin J. E., Levine J. D., Groopman J. E., Henry D. H., Kennedy P., Miles S., Robbins W., Starred B., Zalusky R., Abels R. I., Tsai H. C., Rudnick S. Recombinant human erythropoietin for patients with AIDS treated with Zidovudine. New England Journal of Medicine 1990; 322: 1488–93
   PubMed Web of Science ®Google Scholar
• Stebler C., Tichelli A., Dazzi H., Gratwohl A., Nissen C., Speck B. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroximal nocturnal hemoglobinuria: a pilot study. Experimental Hemmology 1990; 18: 1204–08
   PubMed Web of Science ®Google Scholar
• Schouten H. C., Vellenga E., van Rhenen D. J., de Wolf J. T. M., Coppens P. J. W., Blijham G. H. Recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia 1991; 5: 432–36
   PubMed Web of Science ®Google Scholar
• Stein R. S., Abels R. I., Krantz S. B. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood 1991; 78: 1658–63
   PubMed Web of Science ®Google Scholar
• Bowen D., Culligan D., Jacobs A. The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin. British Journal of Hematology 1991; 77: 419–23
   PubMed Web of Science ®Google Scholar
• van Ramp H., Prinsze-Postema T. G., Kluin P. M., den Ottolander G. J., Beverstock G. C., Willemze R., Fibbe W. E. Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia. British Journal of Hematology 1991; 78: 488–93
   PubMed Web of Science ®Google Scholar
• Abels R. I., Rudnick S. A. Erythropoietin: evolving clinical applications. Experimental Hematology 1991; 19: 842–50
   PubMed Web of Science ®Google Scholar
• Berridge M. V., Fraser J. K., Carter J. M., Lin F. H. Effects of recombinant human erythropoietin on mega-karyocytes and on platelet production in the rat. Blood 1988; 72: 970–77
   PubMed Web of Science ®Google Scholar
• Dessypris E. N., Graber S. E., Krantz D. B., Stone W. J. Effects of recombinant erythropoietin on the concentration and cycling status of human hematopoietic progenitor cells in vivo. Blood 1988; 72: 2060–65
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Young D. C. The role of Colony Simulating Factors in Leukaemogenesis. Clinics in Haematology. Myelodysplasti Sundromes, J. D. Griffin. W. B. Saunders Company, Philadelphia 1986; 995–1002
   Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. British Journal of Hematology 1982; 51: 189–99
   PubMed Web of Science ®Google Scholar
• Kientsch-Engel R., Hallermayer K., Dessauer A. Erythropoietin: From molecular structure to clinical application, C. A. Baldamus, P. L. Scigalla, Koch K.M. Wieczorck. Karger, Basel 1989; 100–105
   Google Scholar
• Rambaldi A., Young D. C., Griffin J. D. Expression of the M-CSF (CSF-1) gene by human monocytes. Blood 1987; 69: 1409–13
   PubMed Web of Science ®Google Scholar
• Clark S. C., Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–37
   PubMed Web of Science ®Google Scholar
• Feinberg A. P., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragmen to high specific activity. Anal. Biochem. 1983; 132: 6–13
   PubMed Web of Science ®Google Scholar
• Erslev A. J. Erythropoietin. New England Journal of Medicine 1991; 324: 1339–44
   PubMed Web of Science ®Google Scholar
• Krantz S. B. Erythropoietin. Blood 1991; 77: 419–34
   PubMed Web of Science ®Google Scholar
• Oster W., Hermann F., Gamm H., Zeile G., Linderman A., Muller G., Brune T., Kraemer H. P., Mertelsmann R. Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J. Clinical Oncol. 1990; 8: 956–962
   PubMed Web of Science ®Google Scholar
• Jacobs A., Janovska-Wieczorek A., Caro J., Bowen D. T., Lewis T. Circulating erythropoietin in patients with myelodysplastic syndromes. British Journal of Haematology 1989; 73: 36–9
   PubMed Web of Science ®Google Scholar
• Cheson B. D. The myelodysplastic syndromes: current approaches to therapy. Annals of Internal Medicine 1990; 112: 932–41
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S., Keating M., LeMaistre A., Hittelmann W. N., McCredie K., Trujillo J. M., Broxmeyer H. E., Henney C., Gutterman J. U. Effects of recombinant human granuiocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. New England Journal of Medicine 1987; 317: 1545–52
   PubMed Web of Science ®Google Scholar
• Antin J. H., Smith B. R., Holmes W., Rosenthal D. S. Phase I/II study of recombinant human granuiocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndromes. Blood 1988; 72: 705–13
   PubMed Web of Science ®Google Scholar
• Ganser A., Volkers B., Greher J., Ottmann O. G., Walther F., Becher R., Bergmann L., Schulz G., Hoelzer D. Recombinant human granuiocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes-a phase I/II trial. Blood 1989; 73: 31–7
   PubMed Web of Science ®Google Scholar
• Kobayashi Y., Okabe T., Ozawa K., Chiba S., Hino M., Miyazono K., Urabe A., Takaku F. Treatment of myelodysplastic syndromes with recombinant human granulo-cyte colony-stimulating factor: a preliminary report. American Journal of Medicine 1989; 86: 178–82
   PubMed Web of Science ®Google Scholar
• Negrin R. S., Haeuber D. H., Nagler A., Olds L. C., Donlon T., Souza L. M., Greenberg P. L. Treatment of myelodysplastic syndromes with recombinant human granulo-cyte colony-stimulating factor: a phase I/II trial. Annals of Internal Medicine 1989; 110: 976–84
   PubMed Web of Science ®Google Scholar
• Champlin R. E., Nimer S. D., Ireland P., Oette D. H., Golde D. W. Treatment of refractory aplastic anemia with recombinant human granuiocyte-macrophage colony-stimulating factor. Blood 1989; 73: 694–9
   PubMed Web of Science ®Google Scholar
• Negrin R. S., Haeuber D. H., Nagler A., Kobayashi Y., Sklar J., Donlon T., Vincent M., Greenberg P. Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 1990; 76: 36–43
   PubMed Web of Science ®Google Scholar
• Young D. C., Griffin J. D. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 1986; 68: 1178–81
   PubMed Web of Science ®Google Scholar